| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/22/2023 | 37.64% | Piper Sandler | $175 → $172 | Maintains | Overweight |
| 11/22/2023 | 53.65% | DA Davidson | $191 → $192 | Maintains | Buy |
| 08/10/2023 | 49.65% | DA Davidson | → $187 | Reiterates | Buy → Buy |
| 05/09/2023 | 49.65% | DA Davidson | → $187 | Reiterates | → Buy |
| 04/21/2023 | 49.65% | DA Davidson | $176 → $187 | Maintains | Buy |
| 04/20/2023 | 42.45% | Piper Sandler | $170 → $178 | Maintains | Overweight |
| 04/12/2023 | 40.85% | DA Davidson | $158 → $176 | Maintains | Buy |
| 03/23/2023 | 36.04% | Piper Sandler | $160 → $170 | Maintains | Overweight |
| 03/03/2023 | 37.64% | BWS Financial | $150 → $172 | Maintains | Buy |
| 03/02/2023 | 26.44% | DA Davidson | $126 → $158 | Maintains | Buy |
| 02/21/2023 | 20.04% | BWS Financial | $125 → $150 | Maintains | Buy |
| 01/31/2023 | -16.77% | Jefferies | $96 → $104 | Maintains | Hold |
| 01/24/2023 | 4.03% | Piper Sandler | $118 → $130 | Maintains | Overweight |
| 11/22/2022 | -16.77% | DA Davidson | $98 → $104 | Maintains | Buy |
| 11/11/2022 | -21.57% | DA Davidson | $94 → $98 | Maintains | Buy |
| 09/09/2022 | -18.37% | Piper Sandler | → $102 | Initiates Coverage On | → Overweight |
| 07/26/2022 | -24.78% | DA Davidson | $87 → $94 | Maintains | Buy |
| 05/16/2022 | -20.77% | Citigroup | → $99 | Upgrades | Neutral → Buy |
| 05/12/2022 | -30.38% | DA Davidson | $131 → $87 | Maintains | Buy |
| 03/03/2022 | -20.77% | Citigroup | $104 → $99 | Maintains | Neutral |
| 12/10/2021 | 4.83% | DA Davidson | $129 → $131 | Maintains | Buy |
| 11/29/2021 | 0.03% | BWS Financial | $120 → $125 | Maintains | Buy |
| 11/18/2021 | -16.77% | Citigroup | $100 → $104 | Maintains | Neutral |
| 11/16/2021 | 3.23% | DA Davidson | $113 → $129 | Maintains | Buy |
| 11/10/2021 | -9.57% | DA Davidson | $100 → $113 | Maintains | Buy |
| 10/26/2021 | -19.97% | DA Davidson | $90 → $100 | Maintains | Buy |
| 08/11/2021 | -19.97% | BWS Financial | $80 → $100 | Maintains | Buy |
| 08/11/2021 | -32.78% | Citigroup | $78 → $84 | Maintains | Neutral |
| 07/20/2021 | -27.98% | DA Davidson | → $90 | Upgrades | Neutral → Buy |
| 04/21/2021 | -35.98% | DA Davidson | $77 → $80 | Maintains | Neutral |
| 03/03/2021 | -39.98% | Citigroup | $56 → $75 | Maintains | Neutral |
| 03/03/2021 | -38.38% | DA Davidson | $55 → $77 | Maintains | Neutral |
| 01/27/2021 | -35.98% | BWS Financial | $60 → $80 | Maintains | Buy |
| 01/26/2021 | -55.99% | DA Davidson | $50 → $55 | Maintains | Neutral |
| 12/02/2020 | -59.99% | DA Davidson | $55 → $50 | Maintains | Neutral |
| 11/11/2020 | -55.99% | DA Davidson | $39 → $55 | Maintains | Neutral |
| 10/28/2020 | -68.79% | DA Davidson | $37 → $39 | Maintains | Neutral |
| 09/10/2020 | -70.39% | DA Davidson | $41 → $37 | Maintains | Neutral |
| 05/13/2020 | -71.19% | Oppenheimer | $29 → $36 | Upgrades | Underperform → Neutral |
| 05/13/2020 | -71.19% | DA Davidson | → $36 | Upgrades | Underperform → Neutral |
| 05/13/2020 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 04/23/2020 | -59.19% | Raymond James | $56 → $51 | Maintains | Outperform |
| 04/23/2020 | -76.79% | DA Davidson | $36 → $29 | Maintains | Underperform |
| 03/20/2020 | -71.19% | DA Davidson | $70 → $36 | Downgrades | Neutral → Underperform |
| 03/04/2020 | -50.38% | Citigroup | $76 → $62 | Maintains | Neutral |
| 03/04/2020 | -49.58% | Raymond James | $82 → $63 | Maintains | Outperform |
| 03/03/2020 | -50.38% | CFRA | $75 → $62 | Maintains | Hold |
| 03/03/2020 | -43.98% | DA Davidson | $76 → $70 | Maintains | Neutral |
| 11/21/2019 | -39.18% | DA Davidson | $82 → $76 | Maintains | Neutral |
| 11/07/2019 | -34.38% | DA Davidson | $78 → $82 | Downgrades | Buy → Neutral |
| 11/07/2019 | -33.58% | Citigroup | $73 → $83 | Maintains | Neutral |
| 06/10/2019 | -37.58% | DA Davidson | → $78 | Upgrades | Neutral → Buy |
| 03/06/2019 | -36.78% | Citigroup | $64 → $79 | Maintains | Neutral |
| 03/05/2019 | -34.38% | Raymond James | $68 → $82 | Maintains | Outperform |
| 03/05/2019 | -32.78% | DA Davidson | $72 → $84 | Downgrades | Buy → Neutral |
What is the target price for Inter Parfums (IPAR)?
The latest price target for Inter Parfums (NASDAQ: IPAR) was reported by Piper Sandler on November 22, 2023. The analyst firm set a price target for $172.00 expecting IPAR to rise to within 12 months (a possible 37.64% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Inter Parfums (IPAR)?
The latest analyst rating for Inter Parfums (NASDAQ: IPAR) was provided by Piper Sandler, and Inter Parfums maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Inter Parfums (IPAR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Inter Parfums, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Inter Parfums was filed on November 22, 2023 so you should expect the next rating to be made available sometime around November 22, 2024.
Is the Analyst Rating Inter Parfums (IPAR) correct?
While ratings are subjective and will change, the latest Inter Parfums (IPAR) rating was a maintained with a price target of $175.00 to $172.00. The current price Inter Parfums (IPAR) is trading at is $124.96, which is out of the analyst's predicted range.